Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.09M Sell
185,238
-512,191
-73% -$6.55M ﹤0.01% 6606
2026
Q2
$8.26M Buy
697,429
+584,200
+516% +$8.54M ﹤0.01% 3877
2026
Q1
$2.03M Sell
113,229
-2,026,655
-95% -$31.5M ﹤0.01% 6034
2025
Q4
$30.9M Buy
2,139,884
+1,138,243
+114% +$15.6M ﹤0.01% 1871
2025
Q3
$15M Buy
1,001,641
+773,195
+338% +$11.3M ﹤0.01% 2693
2025
Q2
$3.34M Buy
+228,446
New +$3.22M ﹤0.01% 4798

Other funds holding JBS

Citadel Advisors's JBS Position: Q3 2026 in Review

Citadel Advisors reduced its JBS (JBS) stake by 73% in Q3 2026, selling an estimated $6.55M and leaving 185,238 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #6606.

Citadel Advisors first reported a position in JBS in Q2 2025 and has held it in 6 quarters since. The position peaked at $30.9M in Q4 2025. 322 funds tracked by Wall St. Rank hold JBS as of Q3 2026.

  • Citadel Advisors held 185,238 shares of JBS worth $2.09M as of Q3 2026.
  • Citadel Advisors sold 512,191 JBS shares in Q3 2026, an estimated $6.55M.
  • JBS made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #6606 holding.
  • Citadel Advisors first reported a position in JBS in Q2 2025 and has held it in 6 quarters since.
  • Citadel Advisors's JBS position peaked at $30.9M in Q4 2025.
  • 322 funds tracked by Wall St. Rank held JBS as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.